about
Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.Effect of salt intake and potassium supplementation on serum renalase levels in Chinese adults: a randomized trial.High Salt Diet Affects Renal Sodium Excretion and ERRα ExpressionCurcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13.Combination of mean platelet volume and the GRACE risk score better predicts future cardiovascular events in patients with acute coronary syndrome.Hemoglobin A1c is associated with severity of coronary artery stenosis but not with long term clinical outcomes in diabetic and nondiabetic patients with acute myocardial infarction undergoing primary angioplastyPlasma Uric Acid as a Prognostic Marker in Patients With Hypertrophic Cardiomyopathy.Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR.TLR4/MyD88/NF-κB signaling and PPAR-γ within the paraventricular nucleus are involved in the effects of telmisartan in hypertension.Resveratrol inhibits high glucose induced collagen upregulation in cardiac fibroblasts through regulating TGF-β1-Smad3 signaling pathway.Targeting erythropoietin protects against proteinuria in type 2 diabetic patients and in zebrafish.IFN-γ aggravates neointimal hyperplasia by inducing endoplasmic reticulum stress and apoptosis in macrophages by promoting ubiquitin-dependent liver X receptor-α degradation.New ST-segment algorithms to determine culprit artery location in acute inferior myocardial infarction.Effect of Salt Intake on Plasma and Urinary Uric Acid Levels in Chinese Adults: An Interventional Trial.A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents.Chest Pain after Aortic Valve Replacement: Rupture of Right Sinus of Valsalva Presenting as Myocardial Infarction.Drug-eluting stent, but not bare metal stent, accentuates the systematic inflammatory response in patients.AMPK Phosphorylation of ACE2 in Endothelium Mitigates Pulmonary Hypertension.Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study.Effects of salt loading and potassium supplement on the circadian blood pressure profile in salt-sensitive Chinese patients.Targeting amino acids metabolic profile to identify novel metabolic characteristics in atrial fibrillationPrognostic significance and dynamic change of plasma macrophage migration inhibitory factor in patients with acute ST-elevation myocardial infarctionPu-erh Tea Ameliorates Atherosclerosis Associated with Promoting Macrophage Apoptosis by Reducing NF-B Activation in ApoE Knockout MiceCorrelation of Triiodothyronine Level with In-Hospital Cardiac Function and Long-Term Prognosis in Patients with Acute Myocardial InfarctionCorrigendum to "Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR"MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasiaZinc supplementation protects against diabetic endothelial dysfunction via GTP cyclohydrolase 1 restorationRelation of Direct, Indirect, and Total bilirubin to Adverse Long-term Outcomes Among Patients With Acute Coronary SyndromeCombination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary interventionMeta-Analysis Comparing Dual Versus Single Antiplatelet Therapy in Combination With Antithrombotic Therapy in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention With Stent ImplantationFasting serum total bile acid level is associated with coronary artery disease, myocardial infarction and severity of coronary lesionsElevated Methylation of FOXP3 (Forkhead Box P3)-TSDR (Regulatory T-Cell-Specific Demethylated Region) Is Associated With Increased Risk for Adverse Outcomes in Patients With Acute Coronary SyndromeRandomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre-specified analysis of the Chinese population from the BERSON clinical trialODYSSEY EAST: Alirocumab efficacy and safety vs ezetimibe in high cardiovascular risk patients with hypercholesterolemia and on maximally tolerated statin in China, India, and ThailandClinical characteristics and protective factors in patients with acute myocardial infarction undergoing in-hospital myocardial free wall rupture: a single-center, retrospective analysisWeighted gene co‑expression network analysis to identify key modules and hub genes associated with atrial fibrillationEosinophils count in peripheral circulation is associated with coronary artery diseaseThe role of monocyte chemotactic protein-induced protein 1 (MCPIP1) in angiotensin II-induced macrophage apoptosis and vulnerable plaque formationAngiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT1R/ROS/p38 MAPK/ADAM17 pathwayA prospective, multicenter, randomized OCT study of early neointimal condition at first and second months after BuMA Supreme stent versus XIENCE stent implantation in high-bleeding-risk coronary artery disease patients: study protocol for a randomiz
P50
Q35808028-8D3F4DC4-3F2F-4132-92A8-9141BAB1C6B2Q36150792-42AD513E-7EAB-4ABC-9821-3188C88AFE86Q36846972-8EA06A5E-05B9-43FF-B44A-1946859D0B48Q38878750-3F756CF7-3299-4304-BCAA-D1F13BF66B3BQ39337726-AC4F69AB-A9EE-4E9A-8F47-412554928CEBQ41318530-6CC9BA96-F25B-4014-8C9A-C5904A624449Q41641567-4FD6695E-D4BA-417A-9378-10C3DB0A3F10Q42130076-D5CA282E-5F76-491F-951F-62E8666C6F1BQ42696095-32D92638-99B7-48B4-85EF-3DE660804C87Q42702979-588EA733-C5B8-4F20-A4B0-761A7BA4BCEEQ47333139-FD5D7EAC-DA7F-4DC8-A8D6-C5D8994117CFQ47966626-018A585B-431C-4FE1-A57D-49DE23A45BE6Q48051730-A534DB84-C33E-403C-B737-63D946F7D5C9Q49372060-A5C41E2E-8564-4FA5-BA17-71263C4F94D5Q50139215-F12929D8-617A-4151-BE48-7F16F46C14B7Q51540822-2038B412-D933-433A-8428-49C26D785B69Q51733330-3F20CEFA-8F3F-4662-A7DD-6D26E932A240Q52430975-54B912B3-F528-4264-928A-FA2D84AE859FQ52682104-A7870C32-14D1-4469-98BC-175A4D25F2F2Q53813321-F2B100CF-0E3F-4FC9-B36F-BD4E0F4442A7Q57021472-F5C43094-9E3A-4522-921A-9E764E6DEB75Q58597439-D0806FD3-587E-4BAB-B2CC-D9CF7607D6A2Q58711608-C870969D-8130-4CBD-94D5-8328F1B66067Q60921521-3AA910D6-EAD9-47F3-B40E-2FD0A68DC4AAQ64071632-702C81AF-81E2-4685-A467-F56F5990CA92Q91010116-6131077A-6E54-4545-87C4-492B1BBE1482Q91301093-CB314DDE-2BBE-460B-BB04-12BE5349355DQ91316376-1B24734C-2BAF-44D0-82FA-2293E757512AQ91332257-87FEBD0A-E6E6-4145-B568-EEDB046A90C1Q91390904-4EF43D24-1C6A-4D86-BA15-B7D33F9B2F38Q91773838-7570B486-6939-42E3-A7D9-CC828B29FB59Q92053843-7BBB015D-0682-43E0-BF56-6D1CD4EF65BEQ92239174-0D3540D7-4E03-4FA6-B079-8C00F053C062Q92286060-DD3C3C25-063D-4324-ACDA-E8F76C0CAFFAQ92295421-BE478F2C-6E21-4EC1-BD07-E52B2CD55E32Q92366651-8BFC8376-A919-4D96-8A8F-5C203F096FA0Q92464082-B27A9D9C-6CAA-4726-9630-C35DBCA5A13EQ92471120-1AED1989-2F79-4038-A020-9C796D67D645Q92475211-6A6A1BCD-76E8-4915-8F85-6AB8EA07C699Q92591303-1A6C21DE-C062-4D7E-8F81-CBE00E1502D5
P50
description
researcher (ORCID 0000-0002-4141-0298)
@en
name
Zuyi Yuan
@en
type
label
Zuyi Yuan
@en
prefLabel
Zuyi Yuan
@en
P31
P496
0000-0002-4141-0298